Pharma: Page 55
-
Commercialization Trends: Commercialization Strategies for Tomorrow
Year in Preview: Commercialization Trends Commercialization Strategies for Tomorrow Trending toward patient focus and collaboration with all stakeholders. Healthcare Consumers Seek Tools and Services Online According to the Cybercitizen Health U.S. 2013 study from Manhattan Research: » 45% of o...
By PharmaVoice Team • Nov. 13, 2013 -
PharmaVOICE 100 - Who's on the List by Section
The Commanders & Chiefs David Berry Pronutria Damian Braga Sanofi Pasteur David Bruggeman Clinical Research Advantage Walter Capone The Multiple Myeloma Research Foundation Steve Collis AmerisourceBergen Corp. Nick Colucci Publicis Healthcare Communications Group Jim Curtis Remedy Health Medi...
By Taren Grom • July 29, 2013 -
Explore the Trendline➔
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
Talent Pool
Pharma Pool Dr. Lynn KRAMER Eisai Creates New Chief Clinical Officer Position Eisai, the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., has appointed Lynn Kramer, M.D., to the newly created position of chief clinical officer of Eisai Product Creation Systems. In this role, Dr. Kramer is respo...
By Ann Grey • May 29, 2013 -
Medical Affairs: The Catalyst for Effective Medical Communications
It has been said knowledge is power. Throughout the ages, healthcare professionals have been revered as powerful not only for their medical acumen but for the ability to heal the sick. Today as therapeutic options become more complex, physicians need to continually update and expand their knowled...
By Debra Joyce • March 28, 2013 -
SHOWCASE FEATURE: Medical Affairs: Beyond the Science
Beyond the Science By Taren Grom Medical affairs professionals are integral to creating new bridges that cross internal departments and connect to new stakeholders to share the increasing amount of scientific information available. With the current healthcare system requiring more data, quality e...
By Taren Grom • March 28, 2013 -
Singapore's Strong Economy Creates Pharma Opportunity
Singapore’s Strong Economy Creates Pharma Opportunity With its developed world economy and strong government support for innovation and business, Singapore offers a healthy environment for life-sciences companies to conduct research, development, and manufacturing. By Kim Ribbink Singapore is a S...
By Kim Ribbink • March 28, 2013 -
Cracking Down on Fake Drugs
Cracking Down on Fake Drugs The fight to protect the pharmaceutical supply chain is a global one, requiring law enforcement, regulatory agencies, and companies to come together for the health of patients. Counterfeit goods are big business. But when it comes to counterfeit medicines, it’s a publi...
By Denise Myshko • March 28, 2013 -
What's New
What’s New The clinical research organization, PharmaNet/i3, has been renamed inVentiv Health Clinical. This renaming reflects the closer alignment between the clinical segment and inVentiv’s commercial and consulting services. “As a global contract research organization, renaming ourselves inVen...
By Ann Grey • March 28, 2013 -
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: Publicis Healthcare Communications Group Launches Publicis Health Media Havas Health Launches New Global Agency Group INC Research Expands Global Consulting Capabilities Cenduit Introduces New Clinical Trial Supply Simulati...
By Taren Grom • Jan. 25, 2013 -
CHILE: Opportunities and Challenges
Chile is considered to be Latin America’s economic powerhouse, but it is a forgotten paradise some say because it is the most politically and economically stable country in Latin America and doesn’t generate the headlines of some of its neighbors. The Pharmaceutical Landscape Geographically ancho...
By Taren Grom • Dec. 27, 2012 -
Talent Pool
Pharmaceutical POOL Melissa Barnes Anne Nobles Lilly Names New Ethics Chief Melissa Barnes has been promoted to chief ethics and compliance officer and senior VP president of enterprise risk management at Eli Lilly and Company. In her new role, Ms. Barnes reports to John Lechleiter, Ph.D., chairm...
By Anne Gray • Dec. 27, 2012 -
Marketing Physicians Trust
In The Tipping Point, author Malcolm Gladwell said: “The most powerful selling of products and ideas takes place not marketer to consumer but consumer to consumer." He couldn’t have been more on point. In fact, according to the latest Edelman Trust Barometer, only 20% of the people surveyed trust...
By Stephanie Brown • Nov. 13, 2012 -
The C-Suite: Executive Insights
Executive Insights CEOs, presidents, and executive management team members from across the industry — pharmaceutical, biotechnology, and service companies — discuss the most crucial factors driving change in the industry, as well as their strategies for meeting the challenges of business in the ...
By Taren Grom • Nov. 13, 2012 -
The Year Ahead: Forging New Paths
Forging New Paths Ever-changing market dynamics will create an industry that is unlike the one we have today. 2013 promises to be as tumultuous as 2012, as the industry looks to contend with the political ping-pong ball that is healthcare. Faced with myriad internal and external pressures, life-s...
By Denise Myshko • Nov. 13, 2012 -
The Entrepreneurs
Alexis Borisy Warp Drive Bio Betsy Brown Trio Clinical Resourcing, an Aptiv Solutions company Faruk Capan Intouch Solutions Marco Chacón, Ph.D. Paragon Bioservices Terri Clevenger Continuum Health Communications Brad Doerschuk PharmaMed Research Michael Fergusson Ayogo Games ...
By PharmaVoice Team • July 28, 2012 -
Letter from the Editor
Letter from the Editor Inspiration… Try not to become a man of success but a man of value. — Albert Einstein. Einstein might have been describing this year’s PharmaVOICE 100 honorees. This distinguished group of individuals — men and women — are committed to achieving results that lead to the g...
By Taren Grom • July 28, 2012 -
Talent Pool
Talent Pool executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Dr. Charlotte KREMER Astellas Names Global Medical Affairs Head Charlotte Kremer, M.D., has joined Astellas Pharma as head of the global medical affairs organization. Dr. Kremer wa...
By Carolyn Gretton • April 27, 2012 -
Tools of the Trade
Tools of the Trade New electronic and web-based applications, sites, and technologies By Carolyn Gretton New Tool from HealthSTAR Provides Virtual Bridge Between KOLs, HCPs Trend: New advances in digital platforms are allowing for the capture of peer-to-peer programs via a digital platform that ...
By Carolyn Gretton • April 27, 2012 -
Generics: Front and Center
The generic drug era is impacting all areas of the industry as the demand for cost-effective medications increases. Denise Myshko As the demand for generics increases, originator companies are moving beyond the traditional end-of-cycle strategies and are deploying more aggressive tactics to not...
By Denise Myshko • Jan. 27, 2012 -
Tools of the Trade
New electronic and web-based applications, sites, and technologies By Carolyn Gretton New Tool from HRM Aims to Improve Medication Adherence, Patient Outcomes Trend: A growing number of healthcare providers are using intuitive technological tools to connect directly with patients to provide info...
By Carolyn Gretton • Jan. 26, 2012 -
Talent Pool
Pharmaceutical POOL Percival BARRETTO-KO Astellas Realigns Executive Team Astellas US, the U.S. affiliate of Tokyo-based Astellas Pharma, has named Percival Barretto-Ko senior VP, corporate strategy and government affairs. Mr. Barretto-Ko was previously executive director, corporate strategy and ...
By PharmaVoice Team • Nov. 11, 2011 -
The Marketers
New Media Mavens These tech-savvy marketers are energized by the possibilities present in the plethora of social media and other cutting-edge message-delivery tools. Alyson Connor • Driving Better Health Behaviors Curious. Passionate. Alyson Connor was a zookeeper. Alyson Connor can make the mos...
By PharmaVoice Team • July 26, 2011 -
The Clinical Specialists
Instinctive Innovators These experts in the clinical arena are evolving research and development practices, technologies, and development models to help bring new products to market faster, more cost-effectively, and with improved safety profiles. Mitchell Katz, Ph.D. • Leading by Example Suppor...
By PharmaVoice Team • July 26, 2011 -
The Researchers & Scientists
Scientific Pathfinders As R&D becomes more focused and specialized, these research experts are leading the way by breaking new ground. Julian Adams, Ph.D., is leading the charge in the war against cancer. Dr. Adams is best known for the discovery and development of Velcade (bortezomib), a pro...
By PharmaVoice Team • July 26, 2011 -
Namaste India: Growth Across the Board
India’s importance in the pharmaceutical space is indisputable. With healthcare booming, a strong medical infrastructure, lower costs, and high levels of patient recruitment and retention, India presents enormous potential. The pharmaceutical business has been growing by 12% to 13% over the past ...
By Kim Ribbink • March 7, 2011